Finance

Lists
Why is CSJA down 3,29%?
Dive Deeper
CSJA:FRA
CSL ADR
29,40 €
-3,29%
(-1,00) 1D
6 նոյ, 08:09:39 GMT+1  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for CSJA...
Open
29,40 €
High
29,40 €
Low
29,40 €
Mkt. cap
96,96 մլրդ
Avg. vol.
10,00
Volume
0,00
52-wk high
43,40 €
52-wk low
12,70 €
No. of employees
29 հզր
Open
29,40 €
High
29,40 €
Low
29,40 €
Mkt. cap
96,96 մլրդ
Avg. vol.
10,00
Volume
0,00
52-wk high
43,40 €
52-wk low
12,70 €
No. of employees
29 հզր
News stories
From web sources and news partners
Profile
CSL Limited is an Australian multinational specialty biotechnology company that researches, develops, manufactures, and markets products to treat and prevent serious human medical conditions. CSL's product areas include blood plasma derivatives, vaccines, antivenom, and cell culture reagents used in various medical and genetic research and manufacturing applications. The company was established in 1916 as Commonwealth Serum Laboratories and was wholly owned by the Australian federal government until its privatisation in 1994. Wikipedia
About CSL ADR
CEOPaul McKenzie
Employees29 հզր
Founded1916
HeadquartersՄելբուրն, Վիկտորիա, Ավստրալիա
SectorHealth Care
Industry-
Websitecsl.com
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025 թ. սեպ
2025 թ. դեկ
2026 թ. մրտ
2026 թ. հնս
Revenue
4,17 մլրդ
4,17 մլրդ
3,73 մլրդ
3,73 մլրդ
Cost of goods sold
1,94 մլրդ
1,94 մլրդ
1,93 մլրդ
1,93 մլրդ
Cost of revenue
1,94 մլրդ
1,94 մլրդ
1,93 մլրդ
1,93 մլրդ
Research and development expenses
300,00 մլն
300,00 մլն
311,50 մլն
311,50 մլն
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
612,50 մլն
612,50 մլն
693,00 մլն
693,00 մլն
Operating expense
912,50 մլն
912,50 մլն
1,00 մլրդ
1,00 մլրդ
Total operating expenses
2,85 մլրդ
2,85 մլրդ
2,93 մլրդ
2,93 մլրդ
Operating income
1,32 մլրդ
1,32 մլրդ
802,00 մլն
802,00 մլն
Other non operating income
-
-
-
-
EBT including unusual items
190,00 մլն
190,00 մլն
-2,23 մլրդ
-2,23 մլրդ
EBT excluding unusual items
1,22 մլրդ
1,22 մլրդ
699,50 մլն
699,50 մլն
Income tax expense
47,00 մլն
47,00 մլն
-597,50 մլն
-597,50 մլն
Effective tax rate
24,74%
24,74%
26,75%
26,75%
Other operating expenses
-
-
-
-
Net income
200,50 մլն
200,50 մլն
-1,49 մլրդ
-1,49 մլրդ
Net profit margin
4,81%
4,81%
-39,92%
-39,92%
Earnings per share
-
-
-
-
Interest and investment income
9,00 մլն
9,00 մլն
6,00 մլն
6,00 մլն
Interest expense
-106,50 մլն
-106,50 մլն
-108,50 մլն
-108,50 մլն
Net interest expenses
-97,50 մլն
-97,50 մլն
-102,50 մլն
-102,50 մլն
Depreciation and amortization charges
-
-
-
-
EBITDA
1,56 մլրդ
1,56 մլրդ
974,00 մլն
974,00 մլն
Gain or loss from assets sale
22,50 մլն
22,50 մլն
500,00 հզր
500,00 հզր
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google Apps